Comparison of Three Groups of Patients Having Low Dose Rate Prostate Brachytherapy: Prostate-Specific Antigen Failure and Overall Survival

Purpose To examine dosimetric and clinical outcomes for Cs-131 radioactive seed implant compared to Pd-103 and I-125.  Background/Significance Cs-131 is a novel isotope with relatively short half-life (9.7 days) that may have clinical advantages in seed implant treatments of prostate cancers. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Booher, Jacquelyn, Domenig, Peter, Goldman, Benjamin, Campbell, Todd, Verdecchia, Kyle, Boura, Judith A, Chuba, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Medical Physics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532522/
https://www.ncbi.nlm.nih.gov/pubmed/34707958
http://dx.doi.org/10.7759/cureus.18185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532522/
https://www.ncbi.nlm.nih.gov/pubmed/34707958
http://dx.doi.org/10.7759/cureus.18185

Ejemplares similares